This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hribal, M. L. Articles by Sesti, G. Search for Related Content PubMed PubMed Citation Articles by Hribal, M. L. Articles by Sesti, G.

The GlyArg⁹⁷² Amino Acid Polymorphism in Insulin Receptor Substrate-1 Affects Glucose Metabolism in Skeletal Muscle Cells¹

Laboratory of Molecular Medicine, Department of Internal Medicine, University of Rome-Tor Vergata (M.L.H., M.F., O.P., P.B., R.L., G.S.), Rome, Italy; Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health (D.L.), Bethesda, Maryland 20892; and Department of Medicine, Columbia University (D.A.), New York, New York 10027-6902

Address all correspondence and requests for reprints to: Giorgio Sesti, M.D., Dipartimento di Medicina Interna, Università di Roma-Tor Vergata, Via Orazio Raimondo, 00173 Rome, Italy. E-mail: sesti{at}uniroma2.it

Molecular scanning of insulin receptor substrate-1 (IRS-1) revealed several amino acid substitutions. The most common IRS-1 variant, a Gly to Arg⁹⁷² change, is more prevalent among type 2 diabetic patients. In this study we overexpressed wild-type and Arg⁹⁷²IRS-1 variant in L6 skeletal muscle cells and examined the functional consequences of this polymorphism on insulin metabolic signaling. L6 cells expressing Arg⁹⁷²-IRS-1 (L6-Arg⁹⁷²) showed a decrease in insulin-stimulated IRS-1-associated phosphatidylinositol 3-kinase (PI 3-kinase) activity compared with L6 cells expressing wild-type IRS-1 (L6-WT) as a consequence of decreased binding of p85 subunit of PI 3-kinase to IRS-1. L6-Arg⁹⁷² exhibited a decrease in both basal and insulin-stimulated glucose transport due to a reduction in the amount of both GLUT1 and GLUT4 translocated to the plasma membrane. Both basal and insulin-stimulated Akt phosphorylations were decreased in L6-Arg⁹⁷² compared with L6-WT. Basal glycogen synthase kinase-3 (GSK-3) activity was increased in L6-Arg⁹⁷² compared with L6-WT, and insulin-induced inactivation of GSK-3 was also reduced in L6-Arg⁹⁷². This change was associated with a significant decrease in insulin-stimulated glucose incorporation into glycogen and glycogen synthase activity in L6-Arg⁹⁷² compared with L6-WT. These results indicate that the Arg⁹⁷²-IRS-1 polymorphism impairs the ability of insulin to stimulate glucose transport, glucose transporter translocation, and glycogen synthesis by affecting the PI 3-kinase/Akt/GSK-3 signaling pathway. The present data indicate that the polymorphism at codon 972 of IRS-1 may contribute to the in vivo insulin resistance observed in carriers of this variant.

This article has been cited by other articles:

				F Sentinelli, E Filippi, M G Cavallo, S Romeo, M Fanelli, and M G Baroni The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPAR{gamma} agonist restores normal cell signaling and differentiation J. Endocrinol., February 1, 2006; 188(2): 271 - 285. [Abstract] [Full Text] [PDF]

				A. Danielsson, A. Ost, F. H. Nystrom, and P. Stralfors Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes J. Biol. Chem., October 14, 2005; 280(41): 34389 - 34392. [Abstract] [Full Text] [PDF]

				G. Sesti, L. Perego, M. Cardellini, F. Andreozzi, C. Ricasoli, P. Vedani, V. Guzzi, M. Marchi, M. Paganelli, G. Ferla, et al. Impact of Common Polymorphisms in Candidate Genes for Insulin Resistance and Obesity on Weight Loss of Morbidly Obese Subjects after Laparoscopic Adjustable Gastric Banding and Hypocaloric Diet J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5064 - 5069. [Abstract] [Full Text] [PDF]

				A. J. McGettrick, E. P. Feener, and C. R. Kahn Human Insulin Receptor Substrate-1 (IRS-1) Polymorphism G972R Causes IRS-1 to Associate with the Insulin Receptor and Inhibit Receptor Autophosphorylation J. Biol. Chem., February 25, 2005; 280(8): 6441 - 6446. [Abstract] [Full Text] [PDF]

				R. Hokanson, S. Miller, M. Hennessey, M. Flesher, W. Hanneman, and D. Busbee Disruption of estrogen-regulated gene expression by dioxin: downregulation of a gene associated with the onset of non-insulin-dependent diabetes mellitus (type 2 diabetes) Human and Experimental Toxicology, December 1, 2004; 23(12): 555 - 564. [Abstract] [PDF]

				J. C. Florez, M. Sjogren, N. Burtt, M. Orho-Melander, S. Schayer, M. Sun, P. Almgren, U. Lindblad, T. Tuomi, D. Gaudet, et al. Association Testing in 9,000 People Fails to Confirm the Association of the Insulin Receptor Substrate-1 G972R Polymorphism With Type 2 Diabetes Diabetes, December 1, 2004; 53(12): 3313 - 3318. [Abstract] [Full Text] [PDF]

				E. Zeggini, J. Parkinson, S. Halford, K. R. Owen, T. M. Frayling, M. Walker, G. A. Hitman, J. C. Levy, M. J. Sampson, E. J.M. Feskens, et al. Association Studies of Insulin Receptor Substrate 1 Gene (IRS1) Variants in Type 2 Diabetes Samples Enriched for Family History and Early Age of Onset Diabetes, December 1, 2004; 53(12): 3319 - 3322. [Abstract] [Full Text] [PDF]

				F. Perticone, A. Sciacqua, A. Scozzafava, G. Ventura, E. Laratta, A. Pujia, M. Federici, R. Lauro, and G. Sesti Impaired Endothelial Function in Never-Treated Hypertensive Subjects Carrying the Arg972 Polymorphism in the Insulin Receptor Substrate-1 Gene J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3606 - 3609. [Abstract] [Full Text] [PDF]

				G. Sesti, M. A. Marini, M. Cardellini, A. Sciacqua, S. Frontoni, F. Andreozzi, C. Irace, D. Lauro, A. Gnasso, M. Federici, et al. The Arg972 Variant in Insulin Receptor Substrate-1 Is Associated With an Increased Risk of Secondary Failure to Sulfonylurea in Patients With Type 2 Diabetes Diabetes Care, June 1, 2004; 27(6): 1394 - 1398. [Abstract] [Full Text] [PDF]

				M. Federici, A. Pandolfi, E. A. De Filippis, G. Pellegrini, R. Menghini, D. Lauro, M. Cardellini, M. Romano, G. Sesti, R. Lauro, et al. G972R IRS-1 Variant Impairs Insulin Regulation of Endothelial Nitric Oxide Synthase in Cultured Human Endothelial Cells Circulation, January 27, 2004; 109(3): 399 - 405. [Abstract] [Full Text] [PDF]

				N. Abate, L. Carulli, A. Cabo-Chan Jr., M. Chandalia, P. G. Snell, and S. M. Grundy Genetic Polymorphism PC-1 K121Q and Ethnic Susceptibility to Insulin Resistance J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5927 - 5934. [Abstract] [Full Text] [PDF]

				M. A. Marini, S. Frontoni, D. Mineo, D. Bracaglia, M. Cardellini, P. de Nicolais, A. Baroni, R. D'Alfonso, M. Perna, D. Lauro, et al. The Arg972 Variant in Insulin Receptor Substrate-1 Is Associated with an Atherogenic Profile in Offspring of Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3368 - 3371. [Abstract] [Full Text] [PDF]

				D. L. Esposito, Y. Li, C. Vanni, S. Mammarella, S. Veschi, F. Della Loggia, R. Mariani-Costantini, P. Battista, M. J. Quon, and A. Cama A Novel T608R Missense Mutation in Insulin Receptor Substrate-1 Identified in a Subject with Type 2 Diabetes Impairs Metabolic Insulin Signaling J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1468 - 1475. [Abstract] [Full Text] [PDF]

				P. Marchetti, R. Lupi, M. Federici, L. Marselli, M. Masini, U. Boggi, S. Del Guerra, G. Patane, S. Piro, M. Anello, et al. Insulin Secretory Function Is Impaired in Isolated Human Islets Carrying the Gly972->Arg IRS-1 Polymorphism Diabetes, May 1, 2002; 51(5): 1419 - 1424. [Abstract] [Full Text] [PDF]

				S. B. Harrap, K. S. Zammit, Z. Y.H. Wong, F. M. Williams, M. Bahlo, A. M. Tonkin, and S. T. Anderson Genome-Wide Linkage Analysis of the Acute Coronary Syndrome Suggests a Locus on Chromosome 2 Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 874 - 878. [Abstract] [Full Text] [PDF]

				R. M.N. Bezerra, V. de Castro, T. Sales, R. Passini Jr, S. T.M. Marba, S. T.O. Saad, and M. J.A. Saad The Gly972Arg Polymorphism in Insulin Receptor Substrate-1 Is Associated With Decreased Birth Weight in a Population-Based Sample of Brazilian Newborns Diabetes Care, March 1, 2002; 25(3): 550 - 553. [Abstract] [Full Text] [PDF]

				G. SESTI, M. FEDERICI, M. L. HRIBAL, D. LAURO, P. SBRACCIA, and R. LAURO Defects of the insulin receptor substrate (IRS) system in human metabolic disorders FASEB J, October 1, 2001; 15(12): 2099 - 2111. [Abstract] [Full Text] [PDF]

				D. L. Esposito, Y. Li, A. Cama, and M. J. Quon Tyr612 and Tyr632 in Human Insulin Receptor Substrate-1 Are Important for Full Activation of Insulin-Stimulated Phosphatidylinositol 3-Kinase Activity and Translocation of GLUT4 in Adipose Cells Endocrinology, July 1, 2001; 142(7): 2833 - 2840. [Abstract] [Full Text] [PDF]

				M. Stumvoll, A. Fritsche, A. Volk, N. Stefan, A. Madaus, E. Maerker, A. Teigeler, M. Koch, F. Machicao, and H. Häring The Gly972Arg Polymorphism in the Insulin Receptor Substrate-1 Gene Contributes to the Variation in insulin Secretion in Normal Glucose-Tolerant Humans Diabetes, April 1, 2001; 50(4): 882 - 885. [Abstract] [Full Text]